Sarcopenia, once considered an inevitable consequence of ageing, is now recognised as a complex syndrome influenced by lifestyle, disease, and acute physiological stress. As global life expectancy rises, its prevalence is increasing, straining healthcare systems [1, 2] due to its association with disability, frailty, and comorbidities [3]. Prevalence estimates range from 0.2% to 86.5% depending on diagnostic criteria [4]. While typically studied in older adults, evidence suggests earlier onset, with rates between 8%-36% in those under 60 and 10%-27% in those aged 60 and older [4]. This variability partly reflects classification differences, with the European Working Group on Sarcopenia in Older People (EWGSOP2) [5] defining primary sarcopenia (ageing-related) and secondary sarcopenia (driven by disease, inactivity, or malnutrition), each posing distinct diagnostic challenges
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.